Tangeretin, a bioactive polymethoxyflavone from immature Citrus aurantium L. fruit, ameliorates experimental colitis by targeting the macrophage β2 integrin Mac-1
- 26 May 2026
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 369, 121921
Abstract
No abstract availableKeywords
Funding Information
- Science and Technology Plan Project of Wenzhou Municipality (YC20250118)
- Natural Science Foundation of Zhejiang Province (LLSSZ25H280003)
- Natural Science Foundation of Zhejiang Province (2060302)
This publication has 52 references indexed in Scilit:
- Revolutionizing pharmacological research of traditional Chinese medicine with single-cell omics technologiesFitoterapia, 2025
- Appropriate Use and Complications of Corticosteroids in Inflammatory Bowel Disease: A Comprehensive ReviewClinical Gastroenterology and Hepatology, 2025
- Phillyrin counters β2 integrin-mediated neutrophil adhesion and chemotaxis to alleviate endotoxin-induced acute lung injury in neonatal ratsBiochemical Pharmacology, 2025
- HDAC inhibitors and IBD: Charting new approaches in disease managementInternational Immunopharmacology, 2025
- Tangeretin alleviates inflammation and oxidative response induced by spinal cord injury by activating the Sesn2/Keap1/Nrf2 pathwayPhytotherapy Research, 2024
- Luteolin ameliorates DSS-induced colitis in mice via suppressing macrophage activation and chemotaxisInternational Immunopharmacology, 2023
- Epidemiology and Pathogenesis of Ulcerative ColitisGastroenterology Clinics of North America, 2020
- CCL2 and CXCL12 Derived from Mesenchymal Stromal Cells Cooperatively Polarize IL-10+ Tissue Macrophages to Mitigate Gut InjuryCell Reports, 2020
- Colonic Pro-inflammatory Macrophages Cause Insulin Resistance in an Intestinal Ccl2/Ccr2-Dependent MannerCell Metabolism, 2016
- The intercellular adhesion molecule (ICAM) family of proteinsImmunologic Research, 1998